Pulmonary Hypertension and the Gut Microbiome

Area of Science:

• Microbiome research
• Cardiovascular pathophysiology
• Pulmonary hypertension

Background:

• The gut microbiome maintains gut integrity and function.
• Gut dysbiosis is linked to systemic conditions like cardiovascular disease.
• Pulmonary hypertension (PH) involves pulmonary circulation changes, leading to right ventricular failure.

Purpose of the Study:

• To review experimental and clinical data on the gut microbiome's role in PH.
• To explore the interaction between gut dysbiosis and PH pathophysiology.
• To identify potential new therapeutic targets for PH.

Main Methods:

• Literature review of experimental studies.
• Analysis of clinical data.
• Synthesis of current research findings.

Main Results:

• Emerging evidence suggests a link between gut dysbiosis and PH development.
• The gut microbiome may influence the pathophysiology of pulmonary hypertension.
• Specific microbial metabolites could play a role in PH.

Conclusions:

• The gut microbiome is a potential factor in pulmonary hypertension.
• Further research is needed to elucidate the precise mechanisms.
• Targeting the gut microbiome may offer novel therapeutic strategies for PH.